These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 29407166

  • 1. High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.
    Chauhan R, Chauhan V, Rao MK, Chaudhary D, Bhagyawant S, Dhaked RK.
    Protein Expr Purif; 2018 Jun; 146():51-60. PubMed ID: 29407166
    [Abstract] [Full Text] [Related]

  • 2. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S, Ponmariappan S, Sharma A, Kamboj DV, Jain AK.
    Protein Pept Lett; 2017 Jun; 24(6):495-502. PubMed ID: 28260503
    [Abstract] [Full Text] [Related]

  • 3. Development of immunodetection system for botulinum neurotoxin serotype E.
    Sarita R, Ponmariappan S, Sharma A, Kamboj DV, Jain AK.
    Indian J Med Res; 2018 Jun; 147(6):603-610. PubMed ID: 30168493
    [Abstract] [Full Text] [Related]

  • 4. Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E.
    Sonkar P, Chauhan V, Chauhan R, Saxena N, Dhaked RK.
    Sci Rep; 2020 Aug 18; 10(1):13932. PubMed ID: 32811892
    [Abstract] [Full Text] [Related]

  • 5. Expression, purification and development of neutralizing antibodies from synthetic BoNT/B LC and its application in detection of botulinum toxin serotype B.
    Ponmariappan S, Jain S, Sijoria R, Tomar A, Kumar O.
    Protein Pept Lett; 2012 Mar 18; 19(3):288-98. PubMed ID: 21933129
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 8. Production of recombinant botulism antigens: a review of expression systems.
    Moreira GM, Cunha CE, Salvarani FM, Gonçalves LA, Pires PS, Conceição FR, Lobato FC.
    Anaerobe; 2014 Aug 01; 28():130-6. PubMed ID: 24930432
    [Abstract] [Full Text] [Related]

  • 9. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y, Barash JR, Lou J, Conrad F, Marks JD, Arnon SS.
    J Infect Dis; 2016 May 15; 213(10):1606-14. PubMed ID: 26936913
    [Abstract] [Full Text] [Related]

  • 10. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.
    Liu Y, Liu X, Chen W, Yu Y, Meng J, Wang J.
    Front Immunol; 2024 May 15; 15():1469919. PubMed ID: 39315101
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E.
    Valipour E, Moosavi ML, Amani J, Nazarian S.
    World J Microbiol Biotechnol; 2014 Jun 15; 30(6):1861-7. PubMed ID: 24469548
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification and characterization of a novel botulinum neurotoxin.
    Zhang S, Masuyer G, Zhang J, Shen Y, Lundin D, Henriksson L, Miyashita SI, Martínez-Carranza M, Dong M, Stenmark P.
    Nat Commun; 2017 Aug 03; 8():14130. PubMed ID: 28770820
    [Abstract] [Full Text] [Related]

  • 19. Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin.
    Matsumura T, Kitamura M, Amatsu S, Yamaguchi A, Kobayashi N, Yutani M, Fujinaga Y.
    Microbiol Immunol; 2024 Oct 03; 68(10):348-358. PubMed ID: 39239735
    [Abstract] [Full Text] [Related]

  • 20. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
    Yu YZ, Zhang SM, Ma Y, Zhu HQ, Wang WB, Du Y, Zhou XW, Wang RL, Wang S, Yu WY, Huang PT, Sun ZW.
    Clin Immunol; 2010 Nov 03; 137(2):271-80. PubMed ID: 20696619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.